NDC 68180-390

IMATINIB MESYLATE

Imatinib

IMATINIB MESYLATE is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is Imatinib Mesylate.

Product ID68180-390_8cef9044-1265-4823-b9db-6eec7f046d5d
NDC68180-390
Product TypeHuman Prescription Drug
Proprietary NameIMATINIB MESYLATE
Generic NameImatinib
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-05-01
Marketing CategoryANDA / ANDA
Application NumberANDA207818
Labeler NameLupin Pharmaceuticals, Inc.
Substance NameIMATINIB MESYLATE
Active Ingredient Strength100 mg/1
Pharm ClassesKinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68180-390-09

90 TABLET, FILM COATED in 1 BOTTLE (68180-390-09)
Marketing Start Date2019-07-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68180-390-09 [68180039009]

IMATINIB MESYLATE TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA207818
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-05-01

Drug Details

Active Ingredients

IngredientStrength
IMATINIB MESYLATE100 mg/1

Pharmacological Class

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]
  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]

NDC Crossover Matching brand name "IMATINIB MESYLATE" or generic name "Imatinib"

NDCBrand NameGeneric Name
0054-0248Imatinib MesylateImatinib Mesylate
0054-0249Imatinib MesylateImatinib Mesylate
0093-7629Imatinib MesylateImatinib Mesylate
0093-7630Imatinib MesylateImatinib Mesylate
0378-2245Imatinib Mesylateimatinib
0378-2246Imatinib Mesylateimatinib
0904-6621Imatinib MesylateImatinib Mesylate
67877-634Imatinib mesylateImatinib mesylate
67877-633Imatinib mesylateImatinib mesylate
72485-202Imatinib mesylateImatinib mesylate
0904-6901Imatinib MesylateImatinib Mesylate
16714-704imatinib mesylateimatinib mesylate
16714-705imatinib mesylateimatinib mesylate
42292-044Imatinib MesylateImatinib Mesylate
42292-043Imatinib MesylateImatinib Mesylate
47335-472imatinib mesylateimatinib mesylate
47335-475imatinib mesylateimatinib mesylate
50268-426Imatinib MesylateImatinib Mesylate
50268-427Imatinib MesylateImatinib Mesylate
51991-376IMATINIB MESYLATEIMATINIB MESYLATE
51991-377IMATINIB MESYLATEIMATINIB MESYLATE
60429-926Imatinib MesylateImatinib Mesylate
60505-2900Imatinib MesylateImatinib Mesylate
60429-925Imatinib MesylateImatinib Mesylate
60687-203Imatinib MesylateImatinib Mesylate
60505-2901Imatinib MesylateImatinib Mesylate
60687-192Imatinib MesylateImatinib Mesylate
64679-794Imatinib MesylateImatinib Mesylate
64679-793Imatinib MesylateImatinib Mesylate
65162-795Imatinib MesylateImatinib Mesylate
65162-794Imatinib MesylateImatinib Mesylate
68180-390IMATINIB MESYLATEIMATINIB MESYLATE
68180-391IMATINIB MESYLATEIMATINIB MESYLATE
51407-270Imatinib MesylateImatinib Mesylate
51407-269Imatinib MesylateImatinib Mesylate
72606-556Imatinib mesylateImatinib mesylate
72606-557Imatinib mesylateImatinib mesylate
0078-0401Gleevecimatinib mesylate
0078-0649Gleevecimatinib mesylate

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.